Global Health Press
The long struggle: vaccines versus malaria

The long struggle: vaccines versus malaria

After clean water, vaccines may have saved more lives than any other public health intervention. Eradication of malaria, a disease that may have killed more humans than any other single cause, likely requires a malaria vaccine. However, after nearly a century of research, today’s only candidate might not pack enough immunological punch to win deployment. Sadly, there are no obvious successors. Goals for vaccines set in 2006 are now approaching, but may not be possible to meet. A quarter century of painstaking work has gone into the vaccine known as RTS,S, now in phase III clinical trials. But after numerous modifications and enhancements, RTS,S still protects only intermittently, 30 to 60 percent of the time. This protection wanes, although over how many years or months is still being studied. The vaccine reduces disease but, so far, not deaths. The organism that causes malaria has made vaccine development a challenge. Malaria is caused...

🔒 Premium Content - For Free

Unlock this content by becoming a Global Health Press subscriber. Join for exclusive articles, expert research, and valuable insights!

List of Abbreviation